The wings of progress: technological and radiopharmaceutical innovations in nuclear medicine.

The editorial discusses technological advancements and radiopharmaceutical innovations in nuclear medicine, focusing on cardiac perfusion assessment, intraoperative PET imaging, and novel radiopharmaceuticals targeting various biological pathways in oncology and neurology. The editorial highlights advancements in scanner technology, such as digital PET and LAFOV PET, as well as dedicated PET scanners for specific anatomical regions. It also discusses the potential of radiopharmaceuticals like [18F] FES, PSMA-targeted agents, and FAPI inhibitors in improving tumour detection and personalized treatment. The editorial emphasizes the importance of balancing technological advancements and radiopharmaceutical innovation to advance patient care in nuclear medicine. [Extracted from the article]